Le Lézard
Classified in: Health
Subjects: CHI, SVY, EXE

Children with Congenital Zika Virus Infection Face Serious Challenges as They Age


ATLANTA, Dec. 14, 2017 /PRNewswire-USNewswire/ -- Most children born with microcephaly ? small head size for age ? and evidence of congenital Zika virus infection face severe health and developmental challenges at ages 19-24 months, according to results from a new investigation led by the Centers for Disease Control and Prevention (CDC) in collaboration with the State Health Secretariat of Paraíba and the Ministry of Health of Brazil.

Centers For Disease Control And Prevention (PRNewsFoto/CDC) (PRNewsFoto/CDC)

The report, published in today's Morbidity and Mortality Weekly Report (MMWR), is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age. These problems include an inability to sit independently, difficulties with sleeping and feeding, seizures, and hearing and vision problems. Many of the children faced challenges in multiple areas.

Although previous publications described the health effects in infants born with microcephaly during the Zika outbreak, this is the first investigation to characterize the health and development of these children as they age. The findings give a more complete picture of the lifelong challenges that will affect children born with microcephaly during the Zika outbreaks in Brazil and elsewhere.

The investigation took place in northeastern Brazil, where Zika affected thousands of children born during 2015 to 2016. The results provide important information to help the United States, Brazil, and other countries prepare for the unprecedented challenges posed for children affected by Zika virus infection.

"Children severely affected by Zika virus are falling far behind age-appropriate developmental milestones, and their challenges are becoming more evident as they age," said CDC Director Brenda Fitzgerald, MD. "Continued monitoring of all children with congenital Zika exposure is critical to understand the full impact of the infection during pregnancy and to support these families for the long-term."

ZODIAC: Long-term follow-up of children born with Zika-related microcephaly

In collaboration with the Ministry of Health of Brazil, scientists working on CDC's Zika Outcomes and Development in Infants and Children (ZODIAC) investigation compiled a comprehensive description of the health and development of 19 children with microcephaly and laboratory evidence of congenital Zika virus. The investigation relied on direct clinical assessments, caregiver interviews, and medical record review. Investigators found that, of the 19 children:

"As children born affected by Zika virus grow up, they will need specialized care from many types of healthcare providers and caregivers," said Georgina Peacock, M.D., M.P.H., director of CDC's Division of Human Development and Disability. "It's important that we use these findings to start planning now for their long-term care and stay vigilant in Zika prevention efforts in the United States and around the world."

For the most current information about Zika virus, visit http://www.cdc.gov/zika/ and https://www.cdc.gov/pregnancy/zika/data/pregnancy-outcomes.html

See a searchable database of specialists who care for infants with congenital Zika virus infection in several U.S. states, the U.S. Virgin Islands, and Puerto Rico at: http://www.zikacareconnect.org/.

ZODIAC: Collaboration and funding

Research for the ZODIAC study has been conducted through a collaboration between the Ministério da Saúde do Brasil (Ministry of Health of Brazil), CDC's National Center on Birth Defects and Developmental Disabilities, CDC's Center for Global Health, CDC's country office in Brazil, and CDC's National Center for Emerging and Zoonotic Infectious Diseases.

The Office of Infectious Disease, Bureau for Global Health, U.S. Agency for International Development provided funds for ZODIAC under the terms of an interagency agreement with CDC. Opinions expressed are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development.

U.S. Department of Health and Human Services

CDC works 24/7 protecting America's health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America's most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Contact: CDC Media Relations 
404-639-3286

 

SOURCE Centers for Disease Control and Prevention (CDC)


These press releases may also interest you

at 11:35
SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac...

at 11:30
SkyQuest projects that the nanotechnology market will attain a value of USD 53.51 billion by 2031, with a CAGR of 36.4% over the forecast period (2024-2031). The increasing demand for nanotechnology in medical research fuels the demand. During...

at 11:30
The Arnold and Mabel Beckman Foundation announced today the selection of its 2024 class of Arnold O. Beckman Postdoctoral Fellows, individuals who underscore the Foundation's mission of supporting basic research in chemical sciences and chemical...

at 11:02
The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP...

at 11:01
Somavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista Purkyn? University and Masaryk Hospital in Ústí nad Labem in the Czech...

at 11:00
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen...



News published on and distributed by: